News | September 11, 2013

MaineHealth Aims to Achieve American Society of Nuclear Cardiology Guidelines with UltraSPECT Technology

Healthcare system selects UltraSPECT nuclear medicine software for lowering dose and reducing exam time

UltraSPECT Xpress.Cardiac, UltraSPECT, nuclear imaging, gamma cameras

UltraSPECT Xpress.Cardiac

September 11, 2013 -- UltraSPECT announced that MaineHealth, a family of hospitals and medical centers throughout Maine, has selected the UltraSPECT Xpress.Cardiac and Xpress3.Cardiac solutions as part of the organization’s strategy for reducing nuclear medicine (NM) dose and complying with the American Society of Nuclear Cardiology (ASNC) final guidelines effective Jan. 1, 2014. Maine Medical Partners (MMP)MaineHealth Cardiology in South Portland is one of 10 facilities within MaineHealth that is installing the product, with others scheduled to continue roll out before the end of 2013. 

"Radiation exposure reduction is a global priority and is readily achievable today through a combination of practices that includes innovative software like that from UltraSPECT," says Mylan Cohen, M.D., medical director of noninvasive cardiology at Maine Medical Center and former ASNC president. "MaineHealth is proud to be a leader in meeting the American Society of Nuclear Cardiology dose-reduction recommendations as we continue to take steps to implement advanced methods to reduce radiation exposure related to cardiac imaging for patients under our care."

ASNC recommends that the nuclear cardiology community limit the total radiation exposure to patients undergoing SPECT/PET myocardial perfusion imaging (MPI) tests to an average of less than or equal to 9 mSv (millisieverts) in 50 percent of studies by 2014. Previously, the average was approximately 12 to 13 mSv for stress and rest imaging. 

MMP — MaineHealth Cardiology conducts nearly 2800 nuclear medicine studies each year. The goal for the facility is to reduce both radiation dose, as well as the length of time of each study. Using the company’s proprietary Wide Beam Reconstruction (WBR) algorithm, the solution enhances the performance of existing NM cameras, enabling a 50 percent reduction in standard radiopharmaceutical injected dose, reducing imaging scan time up to 50 percent for abbreviated exams and greater patient comfort, while maintaining the highest level of image quality. Further, the UltraSPECT Xpress3.Cardiac software is the only solution for lowering dose and shortening exam time that works with all manufacturers’ SPECT cameras to cost-effectively retrofit existing technology for optimal patient outcomes, something that is especially ideal for a large organization like MaineHealth.

The selection of UltraSPECT comes in part as a result of the agreement between UltraSPECT and radiopharmaceutical provider PharmaLogic, under which PharmaLogic is offering the WBR software as part of its patient-centered approach. Healthcare organizations can now streamline the acquisition of UltraSPECT’s software through PharmaLogic versus making a standard capital purchase directly from UltraSPECT.

For more information visit www.ultraspect.com

Related Content

PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Emerging Trends in Nuclear Medicine
Feature | Nuclear Imaging | June 04, 2018 | By Jeff Zagoudis
Nuclear imaging and its various modalities have long played an important role in the diagnosis and treatment of numer
Latest additions to Somatom go. CT platform address advanced clinical fields and applications, including cardiology, CT-guided intervention and dual energy CT. How to lower radiation dose from Computed tomography scanners using ned technology.

Latest additions to Somatom go. CT platform address advanced clinical fields and applications, including cardiology, CT-guided intervention and dual energy CT.

Feature | Computed Tomography (CT) | June 04, 2018 | By Melinda Taschetta-Millane
Recent studies show a rapid increase in patient radiation exposure mainly due to increased use of medical imaging, pa
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
PET Imaging Agent Could Provide Early Diagnosis of Rheumatoid Arthritis

Coronal 18F-FEDAC PET/CT section of a mouse with collagen-induced arthritis. (A) On day 23 and day 37, increased uptake is noted in the front and hind paws of this mouse with collagen-induced arthritis. (B) Predictive performance of day 23 18F-FEDAC uptake for the development of clinical arthritis. ROC = receiver operating characteristic; Sn = sensitivity; Sp = specificity. Credit: Seoul National University and Ewha Womans University, Seoul, South Korea

News | PET Imaging | May 17, 2018
A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint inflammation and...
PET Imaging Shows Protein Clumping May Contribute to Heart Failure Development
News | PET Imaging | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
Samsung Adds S-Vue 3.02 Imaging Engine to GC85A Digital X-ray for Lower Dose
News | Digital Radiography (DR) | May 10, 2018
As part of a growth vision centered on improving patient care quality and safety, Samsung has incorporated the S-Vue 3....
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
Overlay Init